Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Bolt Biotherapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- −6 vs. Q2 2022
- Shares held
- 26.8M
- −39.0K (−0.1%) vs. Q2 2022
- Total value
- $39.7M
- −$15.1M (−27.6%) vs. Q2 2022
- New holders
- 7
- 11 more added
- Sold out
- 13
- 22 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ellevest, Inc. | 32 | $0 | 0.00% | −1,167−97.3% | Reduced |
| Wells Fargo & Company | 145 | $0 | 0.00% | +62+74.7% | Added |
| Barclays PLC | 139 | $0 | 0.00% | −120−46.3% | Reduced |
| Salem Investment Counselors Inc | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 798 | $1.00K | 0.00% | −5,228−86.8% | Reduced |
| Citigroup Inc | 493 | $1.00K | 0.00% | −365−42.5% | Reduced |
| Northwestern Mutual Wealth Management Co | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 481 | $1.00K | 0.00% | −49−9.2% | Reduced |
| China Universal Asset Management Co., Ltd. | 353 | $1.00K | 0.00% | +353 | New |
| JPMorgan Chase & Co | 2,364 | $3.00K | 0.00% | +915+63.1% | Added |
| Federated Hermes, Inc. | 2,143 | $3.00K | 0.00% | +2,143 | New |
| Cubist Systematic Strategies, LLC | 10,228 | $15.0K | 0.00% | −4,384−30.0% | Reduced |
| Dimensional Fund Advisors LP | 10,071 | $15.0K | 0.00% | +10,071 | New |
| Goldman Sachs Group Inc | 12,145 | $18.0K | 0.00% | −21,616−64.0% | Reduced |
| Bank of New York Mellon Corp | 12,685 | $19.0K | 0.00% | −170−1.3% | Reduced |
| Stifel Financial Corp | 14,065 | $21.0K | 0.00% | +246+1.8% | Added |
| Prudential Financial Inc | 16,200 | $24.0K | 0.00% | 00.0% | Unchanged |
| Man Group plc | 17,899 | $26.0K | 0.00% | – | – |
| Tower Research Capital LLC (TRC) | 18,537 | $28.0K | 0.00% | +10,492+130.4% | Added |
| Schonfeld Strategic Advisors LLC | 19,200 | $29.0K | 0.00% | −3,900−16.9% | Reduced |
| Qube Research & Technologies Ltd | 19,286 | $29.0K | 0.00% | −1,187−5.8% | Reduced |
| Occudo Quantitative Strategies LP | 25,380 | $38.0K | 0.00% | −5,436−17.6% | Reduced |
| Eversept Partners, LP | 31,172 | $46.1K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 32,279 | $48.0K | 0.00% | +10,907+51.0% | Added |
| Gsa Capital Partners LLP | 35,561 | $53.0K | 0.01% | −17,130−32.5% | Reduced |
| Bailard, Inc. | 46,383 | $69.0K | 0.00% | +46,383 | New |
| State Street Corp | 48,737 | $72.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 63,779 | $94.0K | 0.03% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 64,995 | $96.0K | 0.00% | −31,105−32.4% | Reduced |
| Morgan Stanley | 71,044 | $105.0K | 0.00% | −339,827−82.7% | Reduced |
| FMR LLC | 79,265 | $117.0K | 0.00% | −497−0.6% | Reduced |
| Ergoteles LLC | 88,174 | $130.0K | 0.00% | −17,481−16.5% | Reduced |
| Bridgeway Capital Management, LLC | 113,200 | $168.0K | 0.00% | +47,700+72.8% | Added |
| Privium Fund Management (UK) Ltd | 116,516 | $172.0K | 0.22% | +116,516 | New |
| Caas Capital Management LP | 116,777 | $173.0K | 0.02% | +116,777 | New |
| Millennium Management LLC | 118,379 | $175.0K | 0.00% | −73,477−38.3% | Reduced |
| Geode Capital Management, LLC | 142,223 | $210.0K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 200,000 | $296.0K | 0.04% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 279,981 | $414.0K | 0.00% | +4,429+1.6% | Added |
| Oasis Management Co Ltd. | 280,000 | $414.0K | 0.07% | +172,500+160.5% | Added |
| Renaissance Technologies LLC | 393,858 | $583.0K | 0.00% | −144,715−26.9% | Reduced |
| Hawkeye Capital Management, LLC | 415,039 | $614.0K | 0.40% | 00.0% | Unchanged |
| BlackRock Inc. | 443,196 | $657.0K | 0.00% | −7,135−1.6% | Reduced |
| Ra Capital Management, L.P. | 533,432 | $789.0K | 0.02% | +83,291+18.5% | Added |
| Newtyn Management, LLC | 600,000 | $888.0K | 0.19% | −148,252−19.8% | Reduced |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $1.06M | 0.07% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 771,059 | $1.14M | 0.02% | +771,059 | New |
| Vanguard Group Inc | 940,269 | $1.39M | 0.00% | +50,477+5.7% | Added |
| Samsara BioCapital, LLC | 1,049,153 | $1.55M | 0.36% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.73M | 1.10% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.80M | 1.02% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,672,000 | $3.96M | 0.17% | +441,750+19.8% | Added |
| Citadel Advisors LLC | 2,752,048 | $4.07M | 0.01% | −3,278−0.1% | Reduced |
| Sofinnova Investments, Inc. | 2,754,437 | $4.08M | 0.26% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,703,991 | $5.48M | 0.26% | −800,000−17.8% | Reduced |
| Vivo Capital, LLC | 3,871,291 | $5.73M | 0.63% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −36,426−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −34,754−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −34,751−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −26,300−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,535−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,994−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,511−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,833−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −188−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |